Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial

The Lancet Diabetes and Endocrinology

Volumn 3, Issue 6, 2015, Pages 413-422

  Ikramuddin, Sayeed ^a   Billington, Charles J ^a   Lee, Wei Jei ^d   Bantle, John P ^a   Thomas, Avis J ^b   Connett, John E ^b   Leslie, Daniel B ^a   Inabnet, William B ^e   Jeffery, Robert W ^c   Chong, Keong ^g   Chuang, Lee Ming ^d   Sarr, Michael G ^h   Jensen, Michael D ^h   Vella, Adrian ^h   Ahmed, Leaque ^f   Belani, Kumar ^b   Schone, Joyce L ⁱ   Olofson, Amy E ^h   Bainbridge, Heather A ^j   Laqua, Patricia S ^c   Wang, Qi ^b   Korner, Judith ^j   more..

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e MOUNT SINAI MEDICAL CENTER   (United States)

^f HARLEM HOSPITAL CENTER   (United States)

^g MIN SHENG GENERAL HOSPITAL   (Taiwan)

^h MAYO CLINIC   (United States)

ⁱ Fairview Health System   (United States)

^j NewYork Presbyterian Hospital   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE IV INHIBITOR; DIURETIC AGENT; FENOFIBRATE; FISH OIL; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; PIOGLITAZONE; SULFONYLUREA; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; ANALBUMINEMIA; ARTICLE; BODY MASS; CALCIUM DEFICIENCY; CONTROLLED STUDY; DEATH; DIET SUPPLEMENTATION; DYSLIPIDEMIA; FALLING; FEMALE; FOLLOW UP; FRACTURE; GLYCEMIC CONTROL; HOSPITAL PERSONNEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INTENTION TO TREAT ANALYSIS; IRON DEFICIENCY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL DEFICIENCY; PANCREAS CANCER; POSTOPERATIVE INFECTION; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK BENEFIT ANALYSIS; STOMACH BYPASS; SYSTOLIC BLOOD PRESSURE; TAIWAN; TEACHING HOSPITAL; TREATMENT OUTCOME; TREATMENT PLANNING; UNITED STATES; VITAMIN D DEFICIENCY; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 2; GASTRIC BYPASS SURGERY; LONGITUDINAL STUDY; METABOLISM; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; RISK REDUCTION;

ADULT; AGED; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK REDUCTION BEHAVIOR; TAIWAN; TREATMENT OUTCOME; UNITED STATES;

EID: 84929957930     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(15)00089-3     Document Type: Article

References (27)

1. Carlsson LMS, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med 2012, 367:695-704.
2. Sjöström L, Peltonen M, Jacobson P, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA 2014, 311:2297-2304.
3. Halperin F, Ding S-A, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg 2014, 149:716-726.
4. Courcoulas AP, Goodpaster BH, Eagleton JK, et al. Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial. JAMA Surg 2014, 149:707-715.
5. Liang Z, Wu Q, Chen B, Yu P, Zhao H, Ouyang X Effect of laparoscopic Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus with hypertension: a randomized controlled trial. Diabetes Res Clin Pract 2013, 101:50-56.
6. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012, 366:1577-1585.
7. Schauer PR, Bhatt DL, Kirwan JP, et al. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med 2014, 370:2002-2013.
8. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008, 299:316-323.
9. Ikramuddin S, Korner J, Lee W-J, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 2013, 309:2240-2249.
10. Standards of medical care in diabetes-2014. Diabetes Care 2014, 37(suppl 1):S14-S80. American Diabetes Association.
11. Bertoni AG, Clark JM, Feeney P, et al. Suboptimal control of glycemia, blood pressure, and LDL cholesterol in overweight adults with diabetes: the Look AHEAD Study. J Diabetes Complicat 2008, 22:1-9.
12. Wong K, Glovaci D, Malik S, et al. Comparison of demographic factors and cardiovascular risk factor control among US adults with type 2 diabetes by insulin treatment classification. J Diabetes Complicat 2012, 26:169-174.
13. Thomas AJ, Bainbridge HA, Schone JL, et al. Recruitment and screening for a randomized trial investigating Roux-en-Y gastric bypass versus intensive medical management for treatment of type 2 diabetes. Obes Surg 2014, 24:1875-1880.
14. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care 2002, 25:2165-2171. Diabetes Prevention Program (DPP) Research Group.
15. Pi-Sunyer X, Blackburn G, Brancati F, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007, 30:1374-1383.
16. Standards of medical care in diabetes2008. Diabetes Care 2008, 31(suppl 1):S12-S54. American Diabetes Association.
17. Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes?. Diabetes Care 2009, 32:2133-2135.
18. Schauer PR, Burguera B, Ikramuddin S, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003, 238:467-484. (discussion 84-85).
19. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
20. Lindholm LH, Ibsen H, Dahlöf B, et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002, 359:1004-1010.
21. Little RJA, Rubin DB Statistical analysis with missing data 2014, John Wiley & Sons, London.
22. Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg 2013, 23:93-102.
23. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009, 122:248-256.
24. Courcoulas AP, Yanovski SZ, Bonds D, et al. Long-term outcomes of bariatric surgery: a National Institutes of Health symposium. JAMA Surg 2014, 149:1323-1329.
25. Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA 2013, 309:2250-2261.
26. Müller-Stich BP, Senft JD, Warschkow R, et al. Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis. Ann Surg 2015, 261:421-429.
27. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012, 366:1567-1576.